Exagen (XGN)
NASDAQ:XGN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 66.58M | $ 55.64M | $ 52.55M | $ 45.56M | $ 48.30M |
| Gross Profit | $ 38.80M | $ 33.11M | $ 29.46M | $ 21.35M | $ 27.71M |
| Operating Income | $ -14.07M | $ -13.64M | $ -22.84M | $ -46.05M | $ -24.07M |
| EBITDA | $ -11.95M | $ -11.14M | $ -19.15M | $ -43.66M | $ -23.10M |
| Net Income | $ -19.95M | $ -15.12M | $ -23.69M | $ -47.39M | $ -26.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 32.22M | $ 22.04M | $ 36.49M | $ 62.39M | $ 99.44M |
| Total Assets | $ 58.02M | $ 44.69M | $ 56.94M | $ 86.22M | $ 123.44M |
| Total Debt | $ 5.40M | $ 23.00M | $ 23.23M | $ 35.20M | $ 28.07M |
| Net Debt | $ -26.82M | $ 969.00K | $ -13.26M | $ -27.19M | $ -71.38M |
| Total Liabilities | $ 40.57M | $ 35.15M | $ 34.25M | $ 43.76M | $ 38.51M |
| Stockholders' Equity | $ 17.45M | $ 9.54M | $ 22.69M | $ 42.46M | $ 84.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.27M | $ -13.79M | $ -15.29M | $ -36.46M | $ -22.64M |
| Operating Cash Flow | $ -13.63M | $ -13.28M | $ -14.46M | $ -32.14M | $ -20.27M |
| Investing Cash Flow | $ -626.00K | $ -515.00K | $ -804.00K | $ -4.32M | $ -2.42M |
| Financing Cash Flow | $ 24.43M | $ -663.00K | $ -10.63M | $ -489.00K | $ 64.68M |